Bio Essence Corporation
BIOE
$0.215
-$0.0201-8.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -13.49% | -83.94% | -- | 182.55% | -18.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.49% | -83.94% | -- | 182.55% | -18.95% |
| Cost of Revenue | -60.37% | -91.66% | -- | 93.74% | 28.44% |
| Gross Profit | 300.99% | -73.38% | -- | 953.57% | -76.65% |
| SG&A Expenses | -38.11% | -42.27% | 524.69% | 780.89% | 31.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.09% | -47.36% | 524.69% | 242.96% | 30.73% |
| Operating Income | 57.82% | 5.47% | -524.69% | -399.22% | -80.22% |
| Income Before Tax | -281.04% | 23.60% | -432.47% | -366.42% | -58.03% |
| Income Tax Expenses | -- | -75.00% | -- | -14.29% | -- |
| Earnings from Continuing Operations | -281.04% | 24.18% | -432.47% | -362.54% | -58.03% |
| Earnings from Discontinued Operations | -- | -- | 264.89% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -281.04% | 24.18% | 174.89% | 9.15% | -58.03% |
| EBIT | 57.82% | 5.47% | -524.69% | -399.22% | -80.22% |
| EBITDA | 55.74% | -1.66% | -594.04% | -613.55% | -86.58% |
| EPS Basic | -280.72% | 30.49% | 164.81% | 23.44% | -38.33% |
| Normalized Basic EPS | 42.86% | 31.37% | -400.00% | -407.69% | -10.53% |
| EPS Diluted | -280.72% | 30.49% | 164.81% | 23.44% | -38.33% |
| Normalized Diluted EPS | 42.86% | 31.37% | -400.00% | -407.69% | -10.53% |
| Average Basic Shares Outstanding | 0.00% | 9.50% | 15.15% | 8.92% | 15.15% |
| Average Diluted Shares Outstanding | 0.00% | 9.50% | 15.15% | 8.92% | 15.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
